Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma

scientific article published on 01 March 2001

Distinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(20010301)91:5<900::AID-CNCR1079>3.0.CO;2-Y
P698PubMed publication ID11251941

P2093author name stringBarlogie B
Lim SH
Badros A
Lue C
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectplasmacytomaQ2090167
P304page(s)900-908
P577publication date2001-03-01
P1433published inCancerQ326041
P1476titleDistinct T-cell clonal expansion in the vicinity of tumor cells in plasmacytoma
P478volume91

Reverse relations

cites work (P2860)
Q82538830Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire
Q35122245Clinical applications of molecular genetic testing in hematologic malignancies: Advantages and limitations
Q87251513Evidence of a skewed T-cell repertoire in patients with light chain amyloidosis
Q57904989Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma
Q44888557Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
Q73356959High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors
Q34391799Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163.
Q92661488Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Q37238171Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology
Q35623772Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

Search more.